Objective: To explore how cytochalasin D (CyD) affects clot initiation and to compare clotting times (CTs) of EXTEM and FIBTEM on rotational thromboelastometry in cardiac surgical patients undergoing cardiopulmonary bypass (CPB). Design: Retrospective cohort study with translational in vitro coagulation experiments. Setting: Single-center, tertiary, academic medical center. Participants: Patients who underwent cardiac surgery with CPB between November 2015 and August 2017. Intervention: None. Measurements and Main Results: The study\u27s primary measurements were CTEXTEM and CTFIBTEM before and after CPB. Additionally, the authors performed translational in vitro coagulation experiments using commercial plasma. In these experiments, the imp...
Unfractionated heparin is the mainstay of anticoagulation during cardiac surgery on cardiopulmonary ...
The intrinsic and extrinsic activation pathways of the hemostatic system converge when prothrombin i...
Aims: Patients using antithrombotic drugs after percutaneous coronary intervention (PCI) are at risk...
Objectives: In the present study, the authors have investigated whether rotational thromboelastometr...
BACKGROUND: Rotational thromboelastometry (ROTEM) is a whole blood point-of-test used to assess the ...
Background: The early detection of coagulopathy helps guide decisions regarding optimal transfusion ...
In the present study, the authors have investigated whether rotational thromboelastometry (ROTEM) co...
Background: Tranexamic acid (TXA) is increasingly used during major surgery with the goal to reduce ...
The thromboelastometry INTEM clotting time (CT) with heparinase (HEPTEM) is frequently used to detec...
Introduction: Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are susceptible ...
Background & Aims: Excessive bleeding occurs after cardiac surgeries on cardiopulmonary bypass (...
Unfractionated heparin is the mainstay of anticoagulation during cardiac surgery on cardiopulmonary ...
BACKGROUND: Viscoelastic point-of-care tests such as thromboelastography (TEG) and rotational thromb...
Clotting time in INTEM (A) corresponds to activated partial thrombin time. Clotting time in INTEM wa...
BACKGROUND: Excessive bleeding after cardiopulmonary bypass (CPB) is risk factor for adverse out...
Unfractionated heparin is the mainstay of anticoagulation during cardiac surgery on cardiopulmonary ...
The intrinsic and extrinsic activation pathways of the hemostatic system converge when prothrombin i...
Aims: Patients using antithrombotic drugs after percutaneous coronary intervention (PCI) are at risk...
Objectives: In the present study, the authors have investigated whether rotational thromboelastometr...
BACKGROUND: Rotational thromboelastometry (ROTEM) is a whole blood point-of-test used to assess the ...
Background: The early detection of coagulopathy helps guide decisions regarding optimal transfusion ...
In the present study, the authors have investigated whether rotational thromboelastometry (ROTEM) co...
Background: Tranexamic acid (TXA) is increasingly used during major surgery with the goal to reduce ...
The thromboelastometry INTEM clotting time (CT) with heparinase (HEPTEM) is frequently used to detec...
Introduction: Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are susceptible ...
Background & Aims: Excessive bleeding occurs after cardiac surgeries on cardiopulmonary bypass (...
Unfractionated heparin is the mainstay of anticoagulation during cardiac surgery on cardiopulmonary ...
BACKGROUND: Viscoelastic point-of-care tests such as thromboelastography (TEG) and rotational thromb...
Clotting time in INTEM (A) corresponds to activated partial thrombin time. Clotting time in INTEM wa...
BACKGROUND: Excessive bleeding after cardiopulmonary bypass (CPB) is risk factor for adverse out...
Unfractionated heparin is the mainstay of anticoagulation during cardiac surgery on cardiopulmonary ...
The intrinsic and extrinsic activation pathways of the hemostatic system converge when prothrombin i...
Aims: Patients using antithrombotic drugs after percutaneous coronary intervention (PCI) are at risk...